Owing to limitations to face-to-face learning events as a result of the COVID- 19 pandemic, Pfizer aims to support enduring online educational programs designed to enhance healthcare practitioner (HCP) knowledge and understanding of the etiology, diagnosis, treatment, and management of patients with axial spondyloarthritis and/or psoriatic arthritis in clinical practice.
V. Kann Rasmussen Foundation—Cultural Resilience and Global Leadership under the Conditions of Environmental Breakdown
The urgency of dealing with unsustainable consumption, the climate crisis, and their consequential impacts to our natural systems are the overall themes for the V. Kann Rasmussen Foundation. The complexity surrounding the impacts of climate change and scaling of our collective mitigation efforts are primary concerns. The Foundation favors projects that consider all life equally important, use a systems approach to address root causes and achieve change, take stock of and tell the truth about the scale, complexity, and urgency of dealing with environmental problems, are based on original thinking, creative ideas, and experimentation, alter power dynamics related to decision-making and influence, and have international significance and perspective, even if they are locally based. The V. Kann Rasmussen Foundation works primarily on international-level issues.
American Association for Cancer Research & The Mark Foundation for Cancer Research—”Science of the Patient” (SOP) Grants
The AACR-The Mark Foundation for Cancer Research “Science of the Patient” (SOP) Grants Program represents a joint effort to stimulate novel research aimed at understanding the influence of the biology of the host (i.e., patient) on the genesis, development, treatment, and survivorship of cancer.
Pfizer and the Crohn’s & Colitis Foundation—Addressing Health Disparities in Inflammatory Bowel Disease
The Crohn’s & Colitis Foundation (Foundation) is initiating this RFP for quality improvement and/or education interventions that aim to reduce the impact of health disparities that exist around vaccine usage and health maintenance in patients with inflammatory bowel disease (IBD). This project is a multi-year endeavor being conducted in collaboration with Pfizer Global Medical Grants (GMG).
Projects that will be considered for Pfizer support will focus on increasing awareness of the role of nuclear scintigraphy (inclusive of Tc- 99m PYP, Tc-99m DPD and Tc-99m HDMP) in the diagnostic work up of patients with suspected cardiac amyloidosis along with other multimodality imaging techniques
Through this RFP it is Pfizer's intent to support educational projects that focus on improving the care of patients with AD by increasing patient and caregiver knowledge of the disease state, preventative measures, and emerging strategies for treatment of AD. Of particular interest are:
The Glaucoma Research Foundation supports new high-impact clinical, epidemiological and laboratory research based on their strategic research goals.
The PhRMA Foundation seeks transformative, multi-stakeholder-driven solutions to address challenges in assessing the value of medicines and health care services to improve patient outcomes and reduce inefficiency.
Research projects that will be considered for Pfizer support will advance the medical knowledge of acromegaly disease, its complications and treatment with pegvisomant.
The mission of the Foundation is to support early stage investigators engaged in basic biomedical research that has the potential to significantly advance the understanding, diagnosis or treatment of disease. Any domestic biomedical institution, whether solely research or educational, is invited to submit one candidate for the Mallinckrodt Board's consideration.
The Leakey Foundation exclusively funds research related to human origins. Priority of funding is commonly given to exploratory phases of promising new research projects that meet the stated purpose of the Foundation. The majority of The Leakey Foundation’s Research Grants awarded to doctoral students are in the $3,000-$15,000 range. Larger grants given to senior scientists and post-doctoral researchers may be funded up to $25,000.
Research projects that will be considered for Pfizer support will advance the medical knowledge of pediatric growth hormone deficiency. Projects submitted may include:
Facebook—Request for proposals on agent-based user interaction simulation to find and fix integrity and privacy issues
Software systems increasingly support communities of users who interact through the platform, elevating the importance and impact of research on integrity and privacy. How do we ensure that such communities remain safe and their data remains private?
Applications must address clinical (hospital or outpatient) or community-related aspects of COVID-19.
Applications must address clinical (hospital or outpatient) or community-related aspects of COVID-19 that focus on an underrepresented minority (URM) patient group.
As part of data.org’s commitment to building the field of data science for social impact, they have launched a $10 million data.org Inclusive Growth and Recovery Challenge. The challenge will seek to elicit proposals for scalable and sustainable data science solutions from and for every part of the world.
The 2020 call for E-Cubed proposals aims to generate and disseminate relevant and usable research to support evidence for education during crises and large-scale disruptions. They call on applicants to share proposals that address the gaps in evidence for education that have been further highlighted as a result of this global emergency. They ask applicants to consider preventative solutions as well as immediate responses to addressing education needs during large-scale disruptions.
Grant funding is to support innovative health services research that will advance the existing knowledge base in the areas of health care financing, delivery, management and/or policy.
Through this RFP, it is Pfizer’s intent to support educational programs that address knowledge gaps for health care providers with the most recent pneumococcal immunization recommendations as described in the updated recommendations of the Advisory Committee on Immunization Practices.
Pfizer & Lilly—2020 Osteoarthritis and Osteoarthritis Pain- Virtual Learning Competitive Grant Program
Through this RFP, it is Pfizer’s intent to support virtual programs for HCPs on Osteoarthritis and Chronic Pain associated with OA patient-centered standard of care and management including pain and function, the biopsychosocial aspects of the disease, the complexities and challenges of care, and the future of OA/OA pain management. Programs targeted towards reviewing data from canceled or virtual rheumatology, pain, primary care or other associated medical conferences are of particular interest.